David S. Burgess

4.4k citations
119 papers · 3.4k indexed · 1 hit paper · h-index 34
Topics
Antibiotics Pharmacokinetics and Efficacy (70 papers)Antibiotic Resistance in Bacteria (50 papers)Antimicrobial Resistance in Staphylococcus (23 papers)
Journals
SHILAP Revista de lepidopterologíaClinical Infectious DiseasesCHEST Journal

In The Last Decade

David S. Burgess

115 papers receiving 3.3k citations

Hit Papers

Comparison of three different in vitro methods of detecti...19962026200620161996100200300400500

Peers

David S. Burgess
Comparison fields: 5 of 145
  • Pharmacology 1.4k
  • Molecular Medicine 1.2k
  • Epidemiology 1.1k
  • Infectious Diseases 744
  • Applied Microbiology and Biotechnology 481
Replace Alfred S. Gin with:
Alfred S. Gin Canada
Ayman Noreddin United States
David E. Nix United States
Ursula Theuretzbacher Austria
Christian Joukhadar Austria
Katherine Young United States
Andrea Novelli Italy
Craig R. Rayner United States
John A. Bosso United States
Santiago Grau Spain
David S. Burgess relative to Alfred S. Gin Canada Alfred S. Gin's profile →
Citations per field
00.5×1.5×
Alfred S. Gin · 1×
Citations per year

Countries citing papers authored by David S. Burgess

Since Specialization
Citations

This map shows the geographic impact of David S. Burgess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Burgess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Burgess more than expected).

Fields of papers citing papers by David S. Burgess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Burgess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Burgess. The network helps show where David S. Burgess may publish in the future.

Co-authorship network of co-authors of David S. Burgess

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Burgess. A scholar is included among the top collaborators of David S. Burgess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Burgess. David S. Burgess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 3
3 1
4 3
5 1
6 7
7 20
8 23
9 53
10 10
11 48
12 61
13 20
14 29
15 13
16 61
17 1
18 22
19 53
20 116

About David S. Burgess

David S. Burgess is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 119 papers that have together received 3.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (70 papers), Antibiotic Resistance in Bacteria (50 papers) and Antimicrobial Resistance in Staphylococcus (23 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Applied Microbiology and Biotechnology (481 citations) and Pharmacology (1.4k citations). David S. Burgess has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Roger L. White, John A. Bosso, Christopher R. Frei, W. Cliff Rutter, Grace C. Lee, James S. Lewis, Donna R. Burgess, Robert L. Talbert, Surakit Nathisuwan and Ronald G. Hall. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026